Please enable JS

Therapeutic

Title Published Pages Region Price
Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Jul 1 2018 215 Global $4,995.00
Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer Jul 1 2018 122 Global $6,995.00
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Jul 1 2018 152 Asia Pacific $4,995.00
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market Jun 1 2018 125 Asia Pacific $4,995.00
Ocular Cancer Drug Development Pipeline Review, 2018 May 23 2018 63 Global $3,995.00
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence May 1 2018 215 Asia Pacific $4,995.00
Influenza A Viral Infections Drug Development Pipeline Review, 2018 Apr 30 2018 188 Global $3,995.00
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs Mar 31 2018 181 Global $4,995.00
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies Mar 31 2018 92 Asia Pacific $4,995.00
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs Mar 1 2018 148 Asia Pacific $4,995.00
Merkel Cell Carcinoma - Pipeline Review, H2 2017 Dec 29 2017 346 Global $2,000.00
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H2 2017 Dec 29 2017 152 Global $2,000.00
Pancreatic Cancer - Pipeline Review, H2 2017 Dec 29 2017 2270 Global $2,500.00
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017 Dec 29 2017 766 Global $2,000.00
High-Grade Glioma - Pipeline Review, H2 2017 Dec 29 2017 333 Global $2,000.00
Neuroendocrine Tumors - Pipeline Review, H2 2017 Dec 29 2017 467 Global $2,000.00
Ovarian Cancer - Pipeline Review, H2 2017 Dec 29 2017 2232 Global $2,500.00
Colorectal Cancer - Pipeline Review, H2 2017 Dec 29 2017 1962 Global $2,500.00
Recurrent Malignant Glioma - Pipeline Review, H2 2017 Dec 29 2017 53 Global $2,000.00
Medulloblastoma - Pipeline Review, H2 2017 Dec 29 2017 197 Global $2,000.00
Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market Dec 27 2017 155 Asia Pacific $4,995.00
COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies Dec 1 2017 120 Asia Pacific $4,995.00
Ependymoma - Pipeline Review, H2 2017 Sep 12 2017 131 Global $2,000.00
Hepatic - Colorectal Metastasis - Pipeline Review, H2 2017 Sep 12 2017 39 Global $2,000.00
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2017 Sep 12 2017 93 Global $2,000.00
Hypopharyngeal Cancer - Pipeline Review, H2 2017 Sep 12 2017 124 Global $2,000.00
Thyroid Cancer - Pipeline Review, H2 2017 Sep 12 2017 490 Global $2,000.00
Malignant Mesothelioma - Pipeline Review, H2 2017 Sep 12 2017 547 Global $2,000.00
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape Aug 1 2017 138 Asia Pacific $4,995.00
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Jul 1 2017 143 Asia Pacific $4,995.00

Pages